Denarase®
GMP Serratia marcescens endonuclease for residual DNA removal in viral vector, vaccine and biologics manufacturing
c-LEcta is part of the Kerry Group and operator of the recently opened Kerry Biotechnology Centre. The Kerry Biotechnology Centre brings together the full biotechnology journey – from enzyme discovery and strain engineering to process development and production – all under one roof. 80+ scientists and innovation experts are focused on driving the discovery of next-generation solutions.
GMP Serratia marcescens endonuclease for residual DNA removal in viral vector, vaccine and biologics manufacturing
Salt-active GMP endonuclease for DNA removal in high-salt viral vector manufacturing workflows
For the quantification of all Serratia marcescens endonucleases including Denarase®, Denarase® High Salt and Benzonase®
Animal-origin-free recombinant trypsin alternative for cell dissociation in cell therapy, stem cell and biomanufacturing workflows
Our enzyme solutions redefine what’s possible in pharma bioprocessing to accelerate innovative drug and vaccine development, optimize production processes and deliver scalable solutions of the highest quality standards.
Kerry Biotechnolgy Centre, c-LEcta GmbH, Alte Messe 3, 04103 Leipzig, Germany - biopharma-enzymes@kerry.com
Website link